The role of patients and carers
An important part of this work has been the involvement of patients and carers. ONG PEM,
in particular, has actively encouraged participation from its members and the wider community, as part of a
broader mobilisation strategy linked to the advocacy process, reinforcing the role of patient voices in shaping
advocacy efforts.
For people living with ME, this is not straightforward. The nature of the condition often
limits the ability to engage consistently. Even so, patient-led contributions remain central to ensuring that
policies reflect lived experience.
This continued involvement highlights a broader point: that progress in ME depends not only on
institutional recognition, but also on sustained input from those directly affected.
A complex and evolving response
Taken together, these efforts point to a more coordinated approach to advocacy. At the same time,
they underline the complexity of the challenge.
Addressing ME requires more than policy commitments at national level. It also involves building
knowledge among healthcare professionals, improving coordination across services, and ensuring that systems are
able to respond to patients with varying levels of severity.
The approach being developed in Spain - combining structured political engagement with concrete
proposals - reflects a broader need across Europe for sustained, coordinated action on ME.
Links to developments across Europe
The work in Spain is part of a wider shift taking place across Europe. In several countries,
there is increasing attention to ME, including developments in research, care structures, and national strategies.
Recent initiatives in Germany and Switzerland point in a similar direction: a gradual move
towards more coordinated responses that combine policy, research, and clinical practice.
Within this context, the role of the European ME Alliance is to support alignment between
national efforts and to promote shared priorities at European level.
Looking ahead
Although the final UN Political Declaration did not include a specific reference to ME,
organisations
involved in the process consider that the meeting has still had an impact.
It has contributed to raising visibility and strengthening connections between national and
international advocacy efforts. It has also helped to consolidate a more structured framework for continued engagement
at both national and European levels.
For Spanish organisations, the work now continues: building on this dialogue, refining proposals,
and working towards more consistent recognition and care for people living with ME.